Total Payments
$37,426
2024 Payments
$1,449
Companies
21
Transactions
240
Medicare Patients
10,684
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$29,287 (78.3%)
Food & Beverage$5,618 (15.0%)
Travel$2,271 (6.1%)
Consulting$250.00 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,275 | 11 | 78.2% |
| Food and Beverage | $5,618 | 221 | 15.0% |
| Travel and Lodging | $2,271 | 6 | 6.1% |
| Consulting Fee | $250.00 | 1 | 0.7% |
| Entertainment | $12.08 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $20,577 | 40 | $0 (2024) |
| PFIZER INC. | $6,389 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $5,721 | 21 | $0 (2023) |
| Abbott Laboratories | $1,264 | 31 | $0 (2024) |
| Boston Scientific Corporation | $695.13 | 8 | $0 (2024) |
| Biosense Webster, Inc. | $637.53 | 26 | $0 (2023) |
| Medical Device Business Services, Inc. | $538.44 | 10 | $0 (2018) |
| Amgen Inc. | $331.83 | 21 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $227.82 | 12 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $195.64 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,449 | 47 | Abbott Laboratories ($669.05) |
| 2023 | $390.71 | 17 | Biosense Webster, Inc. ($95.99) |
| 2022 | $458.69 | 17 | Biosense Webster, Inc. ($138.07) |
| 2021 | $157.32 | 7 | Novartis Pharmaceuticals Corporation ($99.78) |
| 2020 | $196.72 | 9 | Abbott Laboratories ($78.78) |
| 2019 | $290.59 | 17 | Biosense Webster, Inc. ($123.83) |
| 2018 | $6,042 | 45 | Janssen Pharmaceuticals, Inc ($3,410) |
| 2017 | $28,441 | 81 | Janssen Pharmaceuticals, Inc ($17,076) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $173.88 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $173.88 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/05/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/25/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $113.22 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/25/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $73.15 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/25/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $60.96 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/27/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: LUX-Dx_CRM | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | BIOTRONIK INC. | Orsiro Mission (Device) | Food and Beverage | In-kind items and services | $123.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: DIABETES | ||||||
| 08/09/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiology | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: DIABETES | ||||||
| 07/16/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/26/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Vascular | ||||||
| 06/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: DIABETES | ||||||
| 06/21/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: CDS - BG Mini_RM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,616 | 7,840 | $901,448 | $306,641 |
| 2022 | 35 | 3,041 | 8,240 | $951,999 | $326,407 |
| 2021 | 31 | 2,581 | 6,724 | $875,131 | $292,817 |
| 2020 | 29 | 2,446 | 5,392 | $721,139 | $238,408 |
Total Patients
10,684
Total Services
28,196
Medicare Billing
$1.2M
Procedure Codes
129
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 311 | 583 | $134,673 | $52,472 | 39.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 189 | 1,520 | $114,000 | $40,557 | 35.6% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 41 | 41 | $72,201 | $29,369 | 40.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 154 | 1,312 | $73,472 | $23,541 | 32.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 392 | 1,318 | $86,988 | $20,795 | 23.9% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 24 | 24 | $21,600 | $15,904 | 73.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 223 | 754 | $55,796 | $15,489 | 27.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 174 | 578 | $84,388 | $14,327 | 17.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 92 | 145 | $32,335 | $12,929 | 40.0% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 15 | 15 | $19,800 | $9,541 | 48.2% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 13 | 13 | $19,500 | $7,488 | 38.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 365 | 690 | $28,980 | $7,117 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 111 | $17,316 | $6,724 | 38.8% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 27 | 27 | $17,847 | $6,301 | 35.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 42 | $18,228 | $5,688 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $15,620 | $5,462 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 43 | $13,330 | $5,254 | 39.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 77 | 90 | $11,880 | $5,252 | 44.2% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 35 | 216 | $12,744 | $4,090 | 32.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $10,166 | $3,675 | 36.2% |
| 93623 | Programming of heart rhythm stimulation after drug infusion | Facility | 2023 | 44 | 45 | $11,250 | $2,863 | 25.4% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 26 | 33 | $6,633 | $2,530 | 38.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 23 | $2,185 | $1,617 | 74.0% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 21 | 25 | $2,400 | $1,579 | 65.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 12 | 12 | $3,868 | $1,408 | 36.4% |
About Dr. John Jayachandran, M.D
Dr. John Jayachandran, M.D is a Cardiovascular Disease healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730164526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Jayachandran, M.D has received a total of $37,426 in payments from pharmaceutical and medical device companies, with $1,449 received in 2024. These payments were reported across 240 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,275).
As a Medicare-enrolled provider, Jayachandran has provided services to 10,684 Medicare beneficiaries, totaling 28,196 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Fort Worth, TX
- Active Since 12/14/2005
- Last Updated 01/27/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1730164526
Products in Payments
- XARELTO (Drug) $20,599
- ELIQUIS (Drug) $11,937
- AVEIR (Device) $636.95
- Carto 3 System (Device) $585.90
- Corlanor (Drug) $312.25
- WATCHMAN (Device) $262.34
- EMBLEM (Device) $250.00
- CARTO 3 (Device) $234.06
- ENTRESTO (Drug) $197.85
- MULTAQ (Drug) $195.64
- JARDIANCE (Drug) $174.85
- TactiCath Quartz CFA Catheter (Device) $142.16
- FFRct (Device) $133.54
- HeartMate 3 Left Ventricular Dev (Device) $132.87
- Orsiro Mission (Device) $123.89
- VYNDAQEL (Drug) $115.96
- CartoSound (Device) $115.48
- GENERAL THERAPIES (Device) $93.88
- Connectivity and Remote care (Device) $82.31
- FARXIGA (Drug) $74.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fort Worth
Elizabeth Holper, M.d, M.D
Cardiovascular Disease — Payments: $434,185
Cardiovascular Disease $434,185
Dr. Mohanakrishnan Sathyamoorthy, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Dr. Senthil Thambidorai, M.d, M.D
Cardiovascular Disease — Payments: $230,744
Cardiovascular Disease $230,744
Sukesh Burjonroppa, M.d, M.D
Cardiovascular Disease — Payments: $194,389
Cardiovascular Disease $194,389
Dr. Aleem Mughal, Md, MD
Cardiovascular Disease — Payments: $91,055
Cardiovascular Disease $91,055
Mehmet Cilingiroglu, M.d, M.D
Cardiovascular Disease — Payments: $44,151
Cardiovascular Disease $44,151